LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

about

Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology Unusual expression and localization of heat-shock proteins in human tumor cells.

P2860

Q34614894-4EA26F45-9E47-437F-80F0-9F0987E5EDC8 Q41886360-06A117F0-2D75-41A4-BB6C-D0B76D99D01E

P2860

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

Item

http://www.wikidata.org/entity/Q42383966

description

1990 nî lūn-bûn

@nan

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

1990年论文

@zh

1990年论文

@zh-cn

name

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

@en

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

@nl

type

Item

label

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

@en

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

@nl

prefLabel

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

@en

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

@nl

P1476

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes

@en

P2093

A Poggi

http://www.w3.org/2001/XMLSchema#string

C Fortis

http://www.w3.org/2001/XMLSchema#string

E Ferrero

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism.

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.

Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations.

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.

P2888

bjc.1990.372

P304

754-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1990.372

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marina Ferrarini

Maria R. Zocchi

P577

1990-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21454702

http://www.w3.org/2001/XMLSchema#string

P698

1700922

http://www.w3.org/2001/XMLSchema#string

P932

1971538

http://www.w3.org/2001/XMLSchema#string

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

about

P2860

P2860

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932